Biomaxima SA (944) Stock Statistics & Valuation Metrics

Biomaxima SA has a market cap or net worth of €9.37M. The enterprise value is €56.29M.

Biomaxima SA has 4,193,118 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biomaxima SA’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is -0.11%.

The current PE Ratio of Biomaxima SA is ―. Biomaxima SA’s PEG ratio is -5.97.

In the last 12 months, Biomaxima SA had revenue of 60.90M and earned 105.00K in profits. Earnings per share was 0.03.

In the last 12 months, operating cash flow was 602.00K and capital expenditures -1.12M, giving a free cash flow of -516.00K billion.

Biomaxima SA pays an annual dividend of ―, resulting in a dividend yield of ―

Biomaxima SA upcoming earnings date is ―, ―.

Biomaxima SA as a current ratio of 1.74, with Debt / Equity ratio of 33.62%

In the past 12 months, Biomaxima SA has paid 83.00K in taxes.

Biomaxima SA EV to EBITDA ratio is 17.71, with an EV/FCF ratio of 47.30.

Biomaxima SA has €423.00K in cash and marketable securities with €16.12M in debt, giving a net cash position of -€15.70M billion.

Gross margin is 1.75%, with operating margin of -0.22%, and net profit margin of 0.17%.

The average price target for Biomaxima SA is ―, which is 11.43% higher than the current price. The consensus rating is ―